Le Lézard
Classified in: Health

Stratosphere Networks Sponsors Anixter Center's Pure Imagination Event


Tech advisory firm contributes to annual fundraiser to support disability, mental health services

CHICAGO, May 9, 2024 /PRNewswire-PRWeb/ -- Stratosphere Networks has announced it will sponsor the Anixter Center's annual fundraiser. The Pure Imagination event will take place on Thursday, May 23, from 6 to 9 p.m. at Venue West at 221 N. Paulina St. in Chicago.

The Anixter Center provides vital services to the Chicago community, and our team fully supports the organization's life-changing efforts.

The event will include appetizers, cocktails, and networking. Proceeds will support the Anixter Center's work serving individuals in the Chicago area. Since 1919, the Anixter Center has helped hundreds of thousands by providing services for people living with disabilities and mental health needs. The Center also serves those who are Deaf, DeafBlind, and Hard of Hearing.

"We're very pleased to sponsor the Pure Imagination event," said Kevin Rubin, president and CIO of Stratosphere Networks. "The Anixter Center provides vital services to the Chicago community, and our team fully supports the organization's life-changing efforts."    

Stratosphere also sponsored the Anixter Center's annual fundraiser in 2023.

To learn more about the Pure Imagination event, donate, or purchase tickets ($225 per person), please visit the Anixter Center's website.

About Stratosphere Networks

Stratosphere Networks helps businesses bypass the traditional sales process and quickly identify leading Unified Communications as a Service (UCaaS), Contact Center as a Service (CCaaS), customer experience (CX), digital transformation, business process outsourcing (BPO), Infrastructure as a Service (IaaS), data center, managed IT and cybersecurity solutions. Leveraging advanced tools and in-depth knowledge of the technology landscape, our team identifies products and services that position our clients for lasting success. Our team also offers white-glove implementation and project management services, saving our clients time and ensuring the best possible results for their new solutions. With a proven process, we drive end-user adoption with training services, maximize feature functionality with supplier negotiations, and assure lasting high-level performance with ongoing management services. Visit http://www.stratospherenetworks.com for more information.

For more information contact:

Lori Leonardo
847-440-8608
[email protected]

Media Contact

Lori Leonardo, Stratosphere Networks, 847-440-8608, [email protected], https://www.stratospherenetworks.com/

SOURCE Stratosphere Networks


These press releases may also interest you

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

19 mai 2024
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: